塑造DHT评估的未来:对行业挑战,开发商需求和协调的欧洲HTA框架的洞察
Fruzsina Mezei1, Emmanouil Tsiasiotis1, Michele Basile1
1The Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, 00168 Rome, Italy; emmanouil.tsiasiotis@unicatt.it (E.T.); michele.basile@unicatt.it (M.B.); ilaria.sciomenta@altemsadvisory.it (I.S.); elenamaria.calosci@altemsadvisory.it (E.M.C.); debora.antonini@altemsadvisory.it (D.A.); rossella.dibidino@policlinicogemelli.it (R.D.B.); americo.cicchetti@unicatt.it (A.C.).
Journal of market access & health policy
|September 24, 2025
概括
数字健康技术 (DHT) 面临欧洲市场准入障碍,原因是法规分散. 需要统一的医疗技术评估 (HTA) 框架来应对开发者的挑战,并整合现实世界的证据.
科学领域:
- 卫生技术评估 卫生技术评估
- 数字健康数字健康
- 欧洲卫生政策 欧洲卫生政策
背景情况:
- 在欧洲,数字健康技术 (DHT) 的市场准入是复杂的.
- 监管的分散和不同的评估方法带来了重大挑战.
- 了解开发者的观点对于政策制定至关重要.
研究的目的:
- 探索DHT开发人员的感知障碍和优先事项.
- 为制定协调健康技术评估 (HTA) 框架提供信息.
- 为了支持EDiHTA项目的目标.
主要方法:
- 混合方法方法:范围审查,对20名DHT开发商的调查,以及对29名行业代表的采访/焦点小组.
- 在2024年,从10个欧洲国家的创业公司到跨国公司收集的数据.
- 对DHT市场准入的挑战和优先事项的分析.
主要成果:
- 关键的挑战包括不透明的报销,分散的HTA要求和不一致的证据模型.
- 开发人员优先考虑现实世界的证据,可用性,实施因素和生命周期指导.
- 财务和程序性负担不成比例地影响中小企业.
结论:
- 对于代数字开发,需要一个适应性的HTA框架.
- 整合现实世界的证据和减少开发者的不确定性是必不可少的.
- 该EDiHTA项目旨在实现与欧盟法规一致的协调,灵活的HTA方法.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
201
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
201
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K


